Skip to main content

AIM ImmunoTech Inc.

AIM
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000946644

In the last 90 days, AIM ImmunoTech Inc. insiders filed 4 open-market purchases and 0 sales; 18 institutions reported holding it in 13F filings for Q2 2026, worth $325.6K in total; no superinvestor holds it.

13F holders, Q3 2022

Institutional positions in AIM ImmunoTech Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
38
−1 vs. Q2 2022
Shares held
5.78M
−229.3K (−3.8%) vs. Q2 2022
Total value
$3.36M
−$1.32M (−28.2%) vs. Q2 2022
New holders
2
4 more added
Sold out
3
8 more reduced

1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting AIM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2022: 38 institutions
Q1 2021: 38 institutionsQ2 2021: 39 institutionsQ3 2021: 38 institutionsQ4 2021: 43 institutionsQ1 2022: 38 institutionsQ2 2022: 40 institutionsQ3 2022: 38 institutionsQ4 2022: 39 institutionsQ1 2023: 36 institutionsQ2 2023: 34 institutionsQ3 2023: 38 institutionsQ4 2023: 38 institutionsQ1 2024: 33 institutionsQ2 2024: 36 institutionsQ3 2024: 33 institutionsQ4 2024: 35 institutionsQ1 2025: 34 institutionsQ2 2025: 12 institutionsQ3 2025: 15 institutionsQ4 2025: 13 institutionsQ1 2026: 18 institutionsQ2 2026: 18 institutions
Value heldQ3 2022: $3.36M
Q1 2021: $16.8MQ2 2021: $15.5MQ3 2021: $14.7MQ4 2021: $6.86MQ1 2022: $7.12MQ2 2022: $4.68MQ3 2022: $3.36MQ4 2022: $1.67MQ1 2023: $2.05MQ2 2023: $3.01MQ3 2023: $1.97MQ4 2023: $1.83MQ1 2024: $1.93MQ2 2024: $3.15MQ3 2024: $2.43MQ4 2024: $919.3KQ1 2025: $590.0KQ2 2025: $104.8KQ3 2025: $293.9KQ4 2025: $119.8KQ1 2026: $102.8KQ2 2026: $325.6K
Institutions holding AIM and their total value by quarter
QuarterHoldersValue
Q2 202618$325.6K
Q1 202618$102.8K
Q4 202513$119.8K
Q3 202515$293.9K
Q2 202512$104.8K
Q1 202534$590.0K
Q4 202435$919.3K
Q3 202433$2.43M
Q2 202436$3.15M
Q1 202433$1.93M
Q4 202338$1.83M
Q3 202338$1.97M
Q2 202334$3.01M
Q1 202336$2.05M
Q4 202239$1.67M
Q3 202238$3.36M
Q2 202240$4.68M
Q1 202238$7.12M
Q4 202143$6.86M
Q3 202138$14.7M
Q2 202139$15.5M
Q1 202138$16.8M

Institutions, Q3 2022

Shares, value and share of portfolio for each institution holding AIM ImmunoTech Inc.; share changes are against Q2 2022.

Institutions holding AIM in Q3 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Vanguard Group Inc1,987,595$1.16M0.00%00.0%Unchanged
Morgan Stanley1,398,449$814.0K0.00%−200,855−12.6%Reduced
BlackRock Inc.813,460$473.0K0.00%−3,242−0.4%Reduced
Geode Capital Management, LLC382,014$222.0K0.00%00.0%Unchanged
State Street Corp173,103$101.0K0.00%00.0%Unchanged
Verition Fund Management LLC153,002$89.0K0.00%00.0%Unchanged
Bridgeway Capital Management, LLC151,000$88.0K0.00%00.0%Unchanged
Renaissance Technologies LLC124,908$73.0K0.00%+4,500+3.7%Added
Price T Rowe Associates Inc115,700$68.0K0.00%−1,100−0.9%Reduced
Northern Trust Corp86,517$50.0K0.00%−2,190−2.5%Reduced
Cambridge Investment Research Advisors, Inc.47,178$27.0K0.00%+500+1.1%Added
Virtu Financial LLC40,019$23.0K0.00%−14,804−27.0%Reduced
SeaCrest Wealth Management, LLC40,063$23.0K0.00%00.0%Unchanged
Rockefeller Capital Management L.P.40,000$23.0K0.00%00.0%Unchanged
Raymond James Financial Services Advisors, Inc.36,950$22.0K0.00%−500−1.3%Reduced
Susquehanna International Group, LLP28,981$17.0K0.00%+9,911+52.0%Added
Millennium Management LLC29,352$17.0K0.00%+29,352New
Bank of New York Mellon Corp25,268$15.0K0.00%00.0%Unchanged
Captrust Financial Advisors20,000$12.0K0.00%00.0%Unchanged
ForthRight Wealth Management, LLC20,000$12.0K0.01%00.0%Unchanged
LPL Financial LLC15,982$9.00K0.00%00.0%Unchanged
Community Bank, N.A.13,226$8.00K0.00%00.0%Unchanged
Traynor Capital Management, Inc.11,777$6.00K0.00%00.0%Unchanged
SNS Financial Group, LLC10,000$6.00K0.00%00.0%Unchanged
UBS Group AG6,073$4.00K0.00%+731+13.7%Added
Advisor Group Holdings, Inc.2,454$2.00K0.00%−10.0%Reduced
Hoey Investments, Inc1,000$1.00K0.00%00.0%Unchanged
Stephens Consulting, LLC1,500$8730.00%00.0%Unchanged
TD Waterhouse Canada Inc.170$1340.00%00.0%Unchanged
American Portfolios Advisors228$1330.00%00.0%Unchanged
Wells Fargo & Company719$00.00%−10,003−93.3%Reduced
JPMorgan Chase & Co3$00.00%00.0%Unchanged
Huntington National Bank57$00.00%00.0%Unchanged
Bank of America Corp1$00.00%00.0%Unchanged
Credit Suisse AG9$00.00%00.0%Unchanged
Tower Research Capital LLC (TRC)201$00.00%00.0%Unchanged
New Millennium Group LLC33$00.00%00.0%Unchanged
Royal Bank of Canada443$00.00%+443New
Proequities, Inc.0$00.00%−500−100.0%Sold out
Two Sigma Securities, LLC0$00.00%−31,142−100.0%Sold out
Jane Street Group, LLC0$00.00%−10,396−100.0%Sold out
Cordasco Financial Network––––Not filed